Skip to Content
Find More Like This
Return to Search


United States Patent Application

View the Complete Application at the US Patent & Trademark Office
The physiological response of an organism to singlet oxygen is altered by modulating the interaction between an anti-sigma factor, ChrR, and a sigma factor, .sigma..sup.E, or by altering expression of a gene product required for viability in the presence of singlet oxygen.
Donohue, Timothy J. (Middleton, WI), Anthony, Jennifer Rachel (San Lorenzo, CA), Warczak, Kristin L. (Franklin, WI), DuFour, Yann (Madison, WI), Green, Heather (Madison, WI)
12/ 410,066
March 24, 2009
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT [0002] This invention was made with United States government support awarded by the following agencies: National Institute of General Medical Science, GM37509 & GM075273; and Department of Energy, DE-FG02-05ER15653 & ER63232-1018220-0007203. The United States has certain rights in this invention.